๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Raised prostate-specific antigen in adenocarcinoma of the colon

โœ Scribed by M. Yamamoto; H. Hibi; K. Miyake


Book ID
110553621
Publisher
Springer Netherlands
Year
1997
Tongue
English
Weight
290 KB
Volume
29
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparison of serum prostate specific me
โœ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Prostate-specific antigen in screening o
โœ Dr. T. Ming Chu ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB ๐Ÿ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

The use of prostate specific antigen den
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr